Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study

Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study

(2009) R. Berger et al.   EUROPEAN HEART JOURNAL

Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial

(2009) Robert S. Mckelvie et al.   JOURNAL OF CARDIAC FAILURE

Cardiac Resynchronization Therapy

(2009) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

(2009) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

(2008) Jasmine Grewal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Interpretation of Amino-Terminal Pro-Brain Natriuretic Peptide Levels in the HPS and the CORONA Study

(2008) John G.F. Cleland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Perception of symptoms is out of proportion to cardiac pathology in patients with "diastolic heart failure"

(2007) L Ingle et al.   HEART